Role of Gremlin in the Lung Development and Disease

被引:62
作者
Costello, Christine M. [1 ]
Cahill, Edwina [1 ]
Martin, Finian [2 ]
Gaine, Sean [3 ]
McLoughlin, Paul [1 ]
机构
[1] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Sci, Sch Med & Med Sci, Dublin 4, Ireland
[2] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Sci, Sch Biomol & Biomed Sci, Dublin 4, Ireland
[3] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Dept Resp Med, Dublin 4, Ireland
关键词
gremlin; pulmonary hypertension; bone morphogenetic protein; BONE MORPHOGENETIC PROTEIN; PRIMARY PULMONARY-HYPERTENSION; MUSCLE-CELL PROLIFERATION; ANTAGONIST GREMLIN; EXPRESSION; RECEPTOR; SMOOTH; HYPOXIA; GENE; DRM/GREMLIN;
D O I
10.1165/rcmb.2009-0101TR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gremlin is an extracellular glycoprotein that was first identified over a decade ago through its important role in embryonic development, in which it acts as an antagonist of bone morphogenetic protein actions. It plays a critical role in the development of normal airways and the pulmonary circulation in the embryo. More recently, considerable evidence has been presented for a role for gremlin in the pathogenesis of lung diseases, particularly pulmonary hypertension and idiopathic pulmonary fibrosis. The purpose of this article is to review this evidence, consider the potential mechanisms and multicellular actions by which gremlin contributes to disease pathogenesis, and suggest future avenues of research.
引用
收藏
页码:517 / 523
页数:7
相关论文
共 53 条
[1]   Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor [J].
Atkinson, C ;
Stewart, S ;
Upton, PD ;
Machado, R ;
Thomson, JR ;
Trembath, RC ;
Morrell, NW .
CIRCULATION, 2002, 105 (14) :1672-1678
[2]  
Atkinson C., 2001, Journal of Heart and Lung Transplantation, V20, P149, DOI 10.1016/S1053-2498(00)00254-0
[3]   Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators [J].
Balemans, W ;
Van Hul, W .
DEVELOPMENTAL BIOLOGY, 2002, 250 (02) :231-250
[4]   Transcriptional profiling reveals novel markers of liver fibrogenesis - Gremlin and insulin-like growth factor-binding proteins [J].
Boers, Willem ;
Aarrass, Saida ;
Linthorst, Chris ;
Pinzani, Massimo ;
Elferink, Ronald Oude ;
Bosma, Piter .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (24) :16289-16295
[5]   Cutting edge: Bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with slits and act as negative regulators of monocyte chemotaxis [J].
Chen, B ;
Blair, DG ;
Plisov, S ;
Vasiliev, G ;
Perantoni, AO ;
Chen, Q ;
Athanasiou, M ;
Wu, JY ;
Oppenheim, JJ ;
Yang, D .
JOURNAL OF IMMUNOLOGY, 2004, 173 (10) :5914-5917
[6]   Bone morphogenetic proteins [J].
Chen, D ;
Zhao, M ;
Mundy, GR .
GROWTH FACTORS, 2004, 22 (04) :233-241
[7]   Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension [J].
Costello, Christine M. ;
Howell, Katherine ;
Cahill, Edwina ;
McBryan, Jean ;
Konigshoff, Melanie ;
Eickelberg, Oliver ;
Gaine, Sean ;
Martin, Finian ;
McLoughlin, Paul .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 295 (02) :L272-L284
[8]   Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy [J].
Dolan, V ;
Murphy, M ;
Sadlier, D ;
Lappin, D ;
Doran, P ;
Godson, C ;
Martin, F ;
O'Meara, Y ;
Schmid, H ;
Henger, A ;
Kretzler, M ;
Droguett, A ;
Mezzano, S ;
Brady, HR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (06) :1034-1039
[9]  
Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650
[10]   What we know and what we would like to know about genetics and pulmonary arterial hypertension [J].
Durrington, H. J. ;
Morrell, N. W. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 :11-16